International journal of biological macromolecules
Cure8 research brief
Why This Matters
This mouse study identifies a plant polysaccharide that reduced colitis-related inflammation and improved colon histology, suggesting potential microbiome and lipid‑metabolism mechanisms that could inform future research relevant to UC/IBD.
Who Should Pay Attention
Researchers studying IBD mechanisms, microbiome-targeted therapies, and natural-product drug discovery; clinicians interested in emerging preclinical findings; patients generally curious about experimental dietary or botanical approaches (for informational purposes only).
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This is a preclinical (mouse) study testing a plant-derived polysaccharide, not a human trial. The findings show biological effects in mice—improved colon tissue appearance and changes in inflammation-related pathways and metabolites—but do not demonstrate safety or efficacy in people with ulcerative colitis.
Because some protective effects were reproduced by fecal microbiota transfer while others were not, the authors conclude CYP acts through both microbiota-mediated immunoregulation and direct host lipid metabolic effects. These mechanistic insights are hypothesis-generating for future research but are not clinical recommendations.
If you’re curious about dietary supplements or botanical therapies, discuss them with your care team before trying them; effects in mice often do not translate to humans, and purity/dosing/safety vary widely.
Keep In Mind
Results come from a DSS-induced colitis mouse model and mechanistic assays reported in the article abstract. These are preclinical findings and do not establish safety or benefit in humans. The study used direct administration of CYP and fecal microbiota transfer in mice; translational steps would require further preclinical and clinical studies.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationInternational journal of biological macromolecules
AuthorsYushun Qian, Jiaxin Li, Jinzhou Xiao +8 more
InstitutionState Key Laboratory of Food Science and Resources, Nanchang University, Nanchang, 330047, China.
Study typeJournal article
Indexed viaPubMed
Source typeResearch paper
PublishedOct 2, 2026, 12:00 AM
Content availableJournal abstract
Conflict statement: Declaration of competing interest The authors declare no competing financial interests or personal relationships that could influence this work.
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Integrated Multi-Omics Analysis of Antarctica Krill Oil in Alleviating DSS-Induced Colitis and Modulating Gut Microbiota in Mice
This animal study suggests Antarctic krill oil may reduce inflammation and weight loss in a mouse model of ulcerative colitis and works alongside changes in gut microbiota and metabolites—findings that could inform...
The protein extracted from fermented Zanthoxylum bungeanum seeds mitigates DSS-induced ulcerative colitis by orchestrating inflammatory cytokine modulation, counteracting oxidative stress, and safeguarding gut microbiota homeostasis.
The study suggests a fermented seed protein ingredient may reduce inflammation, oxidative stress, and microbiota imbalance in an experimental colitis model — mechanisms relevant to IBD. That could inform future dietary...
Structural Characteristics and Efficacy of Polysaccharides from Fenjiu Vinasse in Alleviating DSS-Induced Ulcerative Colitis
The study identifies a specific polysaccharide fraction (VPS-30) that reduced inflammation and improved gut barrier markers in cell and mouse models of colitis, suggesting a possible new functional-food lead for...